Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components

British Journal of Nutrition

Volumn 98, Issue 4, 2007, Pages 860-867

  Laso, Nuria ^a   Brugué, Emma ^b   Vidal, Josep ^b   Ros, Emilio ^b   Arnaiz, Joan Albert ^b   Carné, Xavier ^b   Vidal, Sergi ^b   Mas, Sergi ^a   Deulofeu, Ramon ^b   Lafuente, Amalia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

BMI; Body fat composition; Conjugated linoleic acid; Man; Metabolic syndrome

Indexed keywords

CONJUGATED LINOLEIC ACID; NATURLINEA; PLACEBO; TONALIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MILK; OBESITY; RANDOMIZED CONTROLLED TRIAL;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BODY COMPOSITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINOLEIC ACIDS, CONJUGATED; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TREATMENT OUTCOME;

EID: 34748896026     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507750882     Document Type: Article

References (41)

1. Pariza MW, Park Y & Cook ME (1999) Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci 52, 107-110.
2. Pariza M, Ashoor S, Chu F & Lund D (1979) Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 7 63-69.
3. Zu HX & Schut HA (1992) Inhibition of 2-amino-3-methylimidazol (4,5-f) quinoline-DNA adduct formation in CDF1 mice by heat-altered derivatives of linoleic acid. Food Chem Toxicol 30, 9-16.
4. Ip C, Singh M, Thompson HJ & Scimeca JA (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54, 1212-1215.
5. Liew C, Schut HA, Chin SF, Pariza MW & Dashwood RH (1995) Protection of conjugated linoleic acids against 2-amino-3-methylimidazol (4,5-f) quinoline-induced colon carcinogenesis in the F344 rat: A study of inhibitory mechanisms. Carcinogenesis 16, 3037-3043.
6. Schonberg S & Krohan HE (1995) The inhibitory effect of conjugated dienoic derivatives (CLA) of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res 15, 1241-1246.
7. Cunningham DC, Harrison LY & Shultz TD (1997) Proliferitive responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 17, 197-203.
8. Wong MW, Chef BP, Wong TS, Hosick HL, Boylston TD & Schultz TD (1997) Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res 17, 987-993.
9. Lee KN, Kritchevsky D & Pariza MW (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19-25.
10. Miller C, Park Y, Pariza MW & Cook M (1994) Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 198, 1107-1112.
11. West DB, Delany JP, Camet PM, Blohm F, Truett AA & Scimeca J (1998) Effects of conjugated linoleic acid on body fat and energy metabolism in mouse. Am J Physiol 275, R667-R672.
12. Park Y, Allbright KJ, Liu W, Storkson JM, Cooj ME & Pariza MW (1997) Effects of conjugated linoleic acid on body composition in mice. Lipids 32, 853-858.
13. German JB, Dilard CJ & Ward RE (2002) Bioactive components in milk. Curr Opin Clin Nutr Metab Care 5, 653-658.
14. Yu L, Adams D & Watkins BA (2003) Comparison of commercial supplements containing conjugated linoleic acids. J Food Composit Anal 16 419-428.
15. Nagao K & Yanagita T (2005) Conjugated fatty acids in food and their health benefits. J Biosci Bioeng 100, 152-157.
16. Gaullier JM, Berven G, Blankson H & Gudmundsen O (2002) Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 37, 1019-1025.
17. Blankson H, Stakkestad JA, Fagertum H, Thom E, Wadstein J & Gudmunsen O (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943-2948.
18. Smedman A & Vessby B (2001) Conjugated linoleic acid suplementation in humans - metabolic effects. Lipids 36, 773-781.
19. Thom E, Wadstein J & Gudmunsen O (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392-396.
20. Riserús U, Amer P, Brismar K & Vessby B (2002) Treatment with dietary trans-10 cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with metabolic syndrome. Diabetes Care 25, 1516-1521.
21. Berven G, Bye A, Hals O & Karlsen OA (2000) Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 102, 455-462.
22. Zambell KL, Keim NL, Van Loan MD, Gale B, Benito P, Kelley DS & Nelson GJ (2000) Conjugated linoleic acid supplementation in humans: Effects on body composition and energy expenditure. Lipids 35, 777-782.
23. Riserús U, Berglund L & Vessby B (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of metabolic syndrome: A randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129-1135.
24. Kamphuis MM, Lejeune MP, Saris WH & Westerterp-Plantenga MS (2003) The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 27, 840-847.
25. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M, Saebo A, Lassel TS, Chardigny JM, Sebedio JL & Beauffere B (2004) Effects of two conjugated linoleic acid isomers on body fat mass in over-weight humans. Obes Res 12, 591-598.
26. Craig CL, Marshall AI, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF & Oja P (2003) International Physical Activity Questionnaire (IPAQ): 12-country reliability and validity. Med Sci Sports Exer 35, 1381-1395.
27. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H & Gudmundsen O (2004) Conjugated linoleic acid supplementation for 1 year reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79, 1118-1125.
28. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H & Gudmundsen O (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135, 778-784.
29. Pariza MW, Park Y & Cook ME (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283-298.
30. Park Y, Storckson JM, Albright KJ, Liu W & Pariza MW (1999) Evidence that the trans-10,cis-12 isomers of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235-241.
31. Evans M, Geigerman C, Cook J, Curtis L, Kuebler B & McIntosh M (2000) Conjugated acid linoleic suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids 35, 899-910.
32. Park Y & Pariza MW (2001) The effects of dietary conjugated nonadecadienoic acid and body composition in mice. Biochim Biophys Acta 1533, 171-174.
33. Kallen C & Lazar M (1996) Antidiabetic thiazolidinediones inhibit leptin on gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93, 5793-5796.
34. Granlud L, Juvet L, Pedersen J & Nebb H (2003) Trans 10, cis 12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res 44 1441-1452.
35. Szymczyk B, Pisulewski PM, Szczurek W & Hanczakowski P (2001) Effects of conjugated linoleic acid on growth performance, feed conversion efficiency, and subsequent carcass quality in broiler chickens. Br J Nutr 85, 465-473.
36. Salas-Salvado J, Marquez-Sandoval F & Bullo M (2006) Conjugated linoleic acid intake in humans: A systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46, 479-488.
37. Tricon S, Burdge G, Kew S, et al. (2004) Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr. 80, 614-620.
38. Noone EJ, Roche HM, Nugent AP & Gibney MJ (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 88, 243-251.
39. Basu S, Riserús U, Turpeinen A & Vessby B (2000) Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99, 511-516.
40. Basu S, Smedman A & Vessby B (2000) Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 468, 33-36.
41. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, Kasai M, Ikemoto S & Ezaki O (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.